Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

NK

NantKwest (NK)

NantKwest Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:NK
일자시간출처헤드라인심볼기업
2019/06/0805:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NKNantKwest Inc
2019/06/0805:32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NKNantKwest Inc
2019/06/0805:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NKNantKwest Inc
2019/06/0705:10Business WireCheryl Cohen Appointed to NantKwest’s Board of DirectorsNASDAQ:NKNantKwest Inc
2019/06/0421:00Business WireNantKwest Announces Durable Complete Responses in Multiple Advanced-Stage Solid Tumor Cancers Following Off-the-Shelf NK Cell...NASDAQ:NKNantKwest Inc
2019/06/0420:45Business WireNantKwest Announces Updated Clinical Results for Nanatinostat (VRx-3996), a Novel HDAC Inhibitor Being Developed in Partnersh...NASDAQ:NKNantKwest Inc
2019/06/0403:50Business WireNantKwest Launches First-in-Human Targeted NK Phase I Clinical Trial of CD19 T-haNK Cell Therapy in Lymphoma PatientsNASDAQ:NKNantKwest Inc
2019/06/0321:00Business WireNantKwest to Present and Provide Update at Upcoming Jefferies 2019 Annual Healthcare ConferenceNASDAQ:NKNantKwest Inc
2019/05/3121:00Business WireNantKwest, NantCell & NantOmics to Provide Updated Preclinical & Clinical Data in Four Abstracts at Part of the American Soci...NASDAQ:NKNantKwest Inc
2019/05/0905:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NKNantKwest Inc
2019/05/0121:00Business WireBrink Biologics Announces Research License Agreement with Worcester Polytechnic Institute for Use of NantKwest’s NK-92®...NASDAQ:NKNantKwest Inc
2019/04/2705:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NKNantKwest Inc
2019/04/0205:09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NKNantKwest Inc
2019/04/0121:00Business WireNantKwest Announces New haNK Natural Killer Cell Patent Issuance Further Expanding Intellectual Property EstateNASDAQ:NKNantKwest Inc
2019/03/2521:00Business WireNantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants & Options in Support of NK’s Natural Kil...NASDAQ:NKNantKwest Inc
2019/03/1818:00Business WireNantKwest Chairman & CEO Dr. Patrick Soon-Shiong to Present Vision for Next Generation Natural Killer Cell Therapies During K...NASDAQ:NKNantKwest Inc
2019/03/1405:09Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NKNantKwest Inc
2019/03/0422:00Business WireNantKwest Signs Worldwide License Agreement with ProMab Biotechnologies to Exclusively Develop Select Next Generation Target...NASDAQ:NKNantKwest Inc
2019/01/0922:00Business WireNantKwest Announces Launch of Merkel Cell Carcinoma Phase II Trial Deploying Novel Triple Combination of off-the-Shelf Natura...NASDAQ:NKNantKwest Inc
2019/01/0522:00Business WireNantKwest to Host 4th Annual Investor/Analyst Day Highlighting Industry Leading R&D and Clinical ProgramsNASDAQ:NKNantKwest Inc
2018/12/0407:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NKNantKwest Inc
2018/12/0401:00Business WireNantKwest to Present Updated Preclinical Data at the 60th Annual Meeting of the American Society of HematologyNASDAQ:NKNantKwest Inc
2018/11/0807:28Business WireNantKwest Announces Promising First in Human Clinical Results of 300 Doses Of CD16 Targeted, Off-The-Shelf Cryopreserved Natu...NASDAQ:NKNantKwest Inc
2018/11/0806:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NKNantKwest Inc
2018/11/0613:23Business WireNantKwest Announces Multiple Presentations at the 2018 Society for Immunotherapy of Cancer ConferenceNASDAQ:NKNantKwest Inc
2018/10/0301:02Business WireNantKwest to Present at 2018 Cantor Global Healthcare ConferenceNASDAQ:NKNantKwest Inc
2018/08/2808:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NKNantKwest Inc
2018/08/0705:10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NKNantKwest Inc
2018/08/0406:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NKNantKwest Inc
2018/07/1408:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NKNantKwest Inc
 검색 관련기사 보기:NASDAQ:NK